StemCyte International, Ltd. (TPE:4178)

Taiwan · Delayed Price · Currency is TWD

17.45

+0.45 (2.65%)

At close: Aug 20, 2026

StemCyte International Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Assets

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2013
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '13 Dec 31, 2013
Cash & Equivalents	2,040	1,680	1,926	1,007	451	137.97
Short-Term Investments	84.97	411.51	337.16	156.79	65.88	-
Cash & Short-Term Investments	2,125	2,092	2,263	1,164	516.88	137.97
Cash Growth	-6.11%	-7.58%	94.50%	125.12%	274.64%	-51.19%
Accounts Receivable	91.6	90.31	101.67	105.4	100.2	157.9
Other Receivables	5.94	5.92	10.14	9.63	4.57	0.59
Receivables	97.53	96.23	111.81	115.04	104.76	158.48
Inventory	402.18	406.85	434.9	429.98	469.96	655.03
Prepaid Expenses	9.42	12.13	22.77	15	9.93	27.89
Other Current Assets	3.56	3.14	2.8	1.64	5.69	0.08
Total Current Assets	2,638	2,610	2,836	1,725	1,107	979.44
Property, Plant & Equipment	316.36	323.97	376.11	163.77	161.41	109.09
Long-Term Investments	0.3	0.94	1.43	1.86	1.85	7.22
Goodwill	-	-	-	-	32.04	-
Other Intangible Assets	9.27	9.69	7.07	8.44	77.72	28.88
Long-Term Deferred Tax Assets	6.71	8.88	11.55	3.44	3.22	20.67
Other Long-Term Assets	132.86	136.7	135.87	114.21	108.05	467.44
Total Assets	3,103	3,090	3,368	2,017	1,491	1,613

Liabilities

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2013
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '13 Dec 31, 2013
Accounts Payable	36.03	37.23	43.26	63.08	36.8	98.33
Accrued Expenses	32.27	41.63	39.3	33.21	22.09	36.43
Current Portion of Long-Term Debt	-	-	-	-	-	21.85
Current Portion of Leases	28.29	28.03	25.3	14.78	25.85	4.89
Current Unearned Revenue	142.07	135.47	134.53	123.92	121.34	45.88
Other Current Liabilities	5.65	8.07	12.76	18.96	25.37	21.91
Total Current Liabilities	244.3	250.43	255.15	253.94	231.46	229.29
Long-Term Debt	-	-	-	-	-	131.88
Long-Term Leases	187.47	190.4	223.84	41.88	13.4	-
Long-Term Unearned Revenue	967.15	888.68	918.41	873.78	866.21	290.22
Long-Term Deferred Tax Liabilities	6.71	8.88	11.55	3.44	16.81	20.67
Other Long-Term Liabilities	13.3	13	9.44	8.1	8.53	17.11
Total Liabilities	1,419	1,351	1,418	1,181	1,136	689.16

Shareholders' Equity

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2013
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '13 Dec 31, 2013
Common Stock	1,933	1,925	1,905	1,614	1,414	778.41
Additional Paid-In Capital	1,287	1,285	2,449	1,531	893.2	1,735
Retained Earnings	-1,461	-1,367	-2,390	-2,185	-1,865	-1,541
Comprehensive Income & Other	-74.86	-104.2	-14.54	-124.15	-87.58	-50.04
Total Common Equity	1,684	1,739	1,949	835.86	355.08	922.08
Minority Interest	-	-	-	-	-	1.49
Shareholders' Equity	1,684	1,739	1,949	835.86	355.08	923.57
Total Liabilities & Equity	3,103	3,090	3,368	2,017	1,491	1,613

Additional Metrics

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2013
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '13 Dec 31, 2013
Total Debt	215.75	218.43	249.14	56.65	39.25	158.62
Net Cash (Debt)	1,909	1,873	2,014	1,107	477.63	-20.65
Net Cash Growth	-5.21%	-7.00%	81.95%	131.76%	-	-
Net Cash Per Share	9.92	9.76	11.17	7.67	3.43	-0.27
Filing Date Shares Outstanding	193.26	192.48	190.53	161.42	139.39	77.84
Total Common Shares Outstanding	193.26	192.48	190.53	161.42	139.39	77.84
Working Capital	2,393	2,360	2,580	1,471	875.75	750.15
Book Value Per Share	8.71	9.03	10.23	5.18	2.55	11.85
Tangible Book Value	1,675	1,729	1,942	827.42	245.33	893.2
Tangible Book Value Per Share	8.67	8.98	10.19	5.13	1.76	11.47
Machinery	271.68	265.71	282.13	258.78	277.16	214.83
Leasehold Improvements	180.63	179.56	197.94	180.14	179.72	28.42